HACKENSACK, N.J.--(BUSINESS WIRE)--ReGen Biologics (OTC: RGBI) recently signed a distribution agreement and initiated marketing for its products, including the Menaflex™ collagen meniscus implant (formerly CMI®) in the United Kingdom (U.K.).
HACKENSACK, N.J.--(BUSINESS WIRE)--ReGen Biologics (OTC: RGBI) recently signed a distribution agreement and initiated marketing for its products, including the Menaflex™ collagen meniscus implant (formerly CMI®) in the United Kingdom (U.K.).
